Back to LGND Stock Lookup

Ligand Pharma (LGND) –

Feb 23, 2015 04:34 PM Form 10-K LIGAND PHARMACEUTICALS For: Dec 31
Feb 20, 2015 04:50 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 19 Filed by: Herman Melanie J
Feb 17, 2015 04:41 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BIOTECHNOLOGY VALUE FUND L P
Feb 13, 2015 10:21 AM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: FMR LLC
Feb 12, 2015 05:07 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: RS INVESTMENT MANAGEMENT CO LLC
Feb 12, 2015 01:43 PM Form SC 13G LIGAND PHARMACEUTICALS Filed by: CARDINAL CAPITAL MANAGEMENT LLC /CT
Feb 12, 2015 07:00 AM Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting
Feb 11, 2015 08:07 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: Herman Melanie J
Feb 11, 2015 08:07 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: FOEHR MATTHEW W
Feb 11, 2015 08:06 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: DeSilva Nishan M
Feb 11, 2015 08:06 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: Berkman Charles S
Feb 11, 2015 08:05 PM Form 4 LIGAND PHARMACEUTICALS For: Feb 10 Filed by: HIGGINS JOHN L
Feb 10, 2015 02:47 PM Form SC 13G LIGAND PHARMACEUTICALS Filed by: VANGUARD GROUP INC
Feb 9, 2015 08:50 AM Form 8-K LIGAND PHARMACEUTICALS For: Feb 09
Feb 9, 2015 08:31 AM Ligand Pharma (LGND) Reports In-Line Q4 EPS; Issues Light Q1 Outlook
Feb 9, 2015 08:30 AM Ligand Reports Fourth Quarter and Full Year 2014 Financial Results
Feb 9, 2015 07:00 AM Ritter Pharmaceuticals Names Matthew W. Foehr to Its Board of Directors
Feb 6, 2015 02:16 PM Trading Radar for 2/9: Hasbro (HAS), Loews (L), Wex, Inc. (WEX), Computer Sciences (CSC) Report
Feb 6, 2015 09:15 AM Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission Seeking Additional Indication for Revolade®
Feb 4, 2015 04:16 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BLAIR WILLIAM & CO/IL
Feb 3, 2015 10:18 AM Ligand's (LGND) License with Sermonix Demonstrates Great Example of Core Business Model - Roth Capital
Feb 3, 2015 10:12 AM Ligand Pharma (LGND), Sermonix Enter Licensing Agreement for Lasofoxifene
Feb 3, 2015 08:30 AM Ligand Signs License Agreement with Sermonix for Lasofoxifene
Feb 2, 2015 04:49 PM Form 8-K LIGAND PHARMACEUTICALS For: Jan 27
Feb 2, 2015 04:30 PM Ligand Promotes Matthew W. Foehr to President
Jan 28, 2015 08:30 AM Ligand to Present at BIO CEO and RBC Capital Markets Global Healthcare Conferences in February
Jan 28, 2015 07:57 AM Roth Remains Positive on Ligand (LGND) Following Kyprolis Q4 Sales Data, sNDA Filing (AMGN)
Jan 27, 2015 09:00 AM Ligand to Report Fourth Quarter Results on February 9th
Jan 21, 2015 02:30 PM Roth Affirms Curis (CRIS) at 'Buy' Following Aurigene Deal; Cuts PT to $6 on Dilution
Jan 9, 2015 04:45 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BlackRock Inc.
Jan 9, 2015 10:15 AM Ligand Partner Retrophin Receives Orphan Drug Designation for Sparsentan
Jan 8, 2015 08:35 AM Ligand Pharma (LGND) Partner Reports Positive Top-Line Data from Two PROCEED Phase 3s
Jan 8, 2015 08:30 AM Ligand Partner Melinta Therapeutics Reports Positive Phase 3 Results for Captisol-enabled™ Delafloxacin IV
Jan 5, 2015 07:47 PM Form 4 LIGAND PHARMACEUTICALS For: Dec 31 Filed by: Berkman Charles S
Jan 5, 2015 07:47 PM Form 4 LIGAND PHARMACEUTICALS For: Dec 31 Filed by: FOEHR MATTHEW W
Jan 5, 2015 07:47 PM Form 4 LIGAND PHARMACEUTICALS For: Dec 31 Filed by: Herman Melanie J
Jan 5, 2015 02:48 PM Form 4 LIGAND PHARMACEUTICALS For: Dec 31 Filed by: Aryeh Jason
Dec 26, 2014 02:43 PM Roth Positive on Spectrum Pharma (SPPI) Following CE-Melphalan NDA Filing (LGND)
Dec 26, 2014 07:30 AM Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for Captisol-Enabled™ Melphalan
Dec 26, 2014 07:01 AM Spectrum Pharma (SPPI) Files CE-Melphalan NDA
Dec 26, 2014 07:00 AM Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan
Dec 22, 2014 09:21 AM Ligand Pharma (LGND) Reports Submission of Promacta sNDA (GSK)
Dec 22, 2014 09:20 AM Ligand Partner GlaxoSmithKline Announces US Regulatory Submission Seeking Additional Indication for Promacta®
Dec 19, 2014 02:29 PM Roth Comments on Ligand Pharma (LGND) Following EU Marketing Authorization of Duavive
Dec 19, 2014 11:36 AM Ligand Pharma (LGND) Announces EU Approval of DUAVIVE as Estrogen Deficiency Treatment (PFE)
Dec 19, 2014 11:30 AM Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus
Dec 1, 2014 04:37 PM Deutsche Bank Starts Ligand Pharma (LGND) at Buy
Nov 26, 2014 03:00 PM Form 4 LIGAND PHARMACEUTICALS For: Nov 24 Filed by: LAMATTINA JOHN L
Nov 18, 2014 11:42 AM Ligand Pharma (LGND) Offers Three-Year Financial Outlook; Updates on Business Model, Growth Factors
Nov 18, 2014 10:02 AM Form 8-K LIGAND PHARMACEUTICALS For: Nov 18

Back to LGND Stock Lookup